Guidelines for Authors Aims and Scope
The rapidly expanding area of research known as neuroimmunomodulation explores the way in which the nervous system interacts with the immune system via neural, hormonal, and paracrine actions. Encompassing both basic and clinical research, 'Neuroimmunomodulation' reports on all aspects of these interactions. Basic investigations consider all neural and humoral interactions from molecular genetics through cell regulation to integrative systems of the body. The journal also aims to clarify the basic mechanisms involved in the pathogenesis of the CNS pathology in AIDS patients and in various neurodegenerative diseases. Although primarily devoted to research articles, timely reviews will be published on a regular basis. To ensure high quality, all papers will be reviewed by at least two referees, with every effort made to maintain a short publication time.
Manuscripts
should be submitted using the online submission website at:
www.karger.com/nim
Authors are asked to suggest three to four potential reviewers for their manuscript. These experts on the topic of the article should not be from the same institution as the author(s). The names and the full postal and e-mail addresses of potential reviewers should be submitted with each article. Editors will consider these suggestions but are not bound by them.
Should you experience any problems with your submission, please contact the Editorial Office:
nim@karger.ch

Conditions
All manuscripts are subject to editorial review. Manu scripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication. Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Neuroimmunomodulation' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications. Most reviews are solicited by the editors. Unsolicited reviews may also be considered, but authors should send a brief proposal to the editorial office, summarizing the topic of the proposed review and 4-5 key references. Manuscripts should be written in English. They should contain unpublished results of research work, and should be as concise as possible. They should be typewritten on 'letter-quality' paper printed on one side of the sheet only and double spaced with a wide margin. Please send the original and three first-class copies of the manuscript. One set of the original illustrations plus three copies is adequate, except in the case of photomicrographs or other illustrations that do not reproduce well in Xerox or related types of copying equipment. In these instances, it will be necessary to submit four clear prints of each illustration for distribution to the reviewers. The final version of your manuscript and illustrations should be submitted on disk. For details refer to 'Disk Submission' or www.karger.com/journals/disksub.htm. Editorial review and copyediting will be executed from the disk version of your manuscript. The following presentation is recommended: Abstract, Introductory statement on the purpose of the studies, Materials and Methods, Results, Discussion, and References. Commonly accepted abbreviations (e.g. ACTH, TSH, DNA) may be used throughout the text and tables, but a definition should be provided the first time each abbreviation is used. Please limit abbreviations to those in common use, and avoid other abbreviations and acronyms. Contributions will generally be printed in order of acceptance for publication. Contributors should know that one of the criteria considered in reviewing manuscripts is the humane and proper treatment of animals. The editors realize that the use of anesthetics, analgesics, and tranquilizers would defeat the purpose of some experiments. However, the use of painful or otherwise noxious stimuli must be carefully and thoroughly justified in the paper. Papers that do not meet these criteria will not be accepted for publication.
Rapid communications:
Manuscripts intended for rapid communication must present new findings of sufficient importance to justify their accelerated appearance. Double-spaced manuscripts cannot exceed 7 pages, including figures, tables and references; longer manuscripts will be returned. Rapid communications are subject to the usual editorial review and are published within 2 months following acceptance. Proofs are sent to the Editors and to the authors.
Arrangement
All pages should be numbered consecutively and carry the author's name in the upper right corner.
Title page: The first page of each paper should carry the title, the authors' full first and last names, and the name of the institute or department where the authors conducted their research work. In addition, the following should be put on the title page: 1. A short title for use as a running head; 2. A list of 3-9 key words that reflect the content of the paper; 3. The name and complete mailing address, phone and fax numbers as well as email address of the individual to whom correspondence, proofs, and requests for reprints should be addressed. Footnotes: Avoid footnotes if at all possible. When essential, they should be numbered consecutively and typed at the foot of the appropriate page. Tables (numbered in arabic of each illustration, indicate its number, the author's name, and 'top' with a soft pencil. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800-1200 dpi.
Tables and illustrations:
Color illustrations
Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends. Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 800.-per page.
Acknowledgments, including, where relevant, credit to the sources of grant support, should be placed before the references.
References:
In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of all the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org). Papers that have been submitted to a journal but are not yet accepted should not be listed in the bibliography, but the data in them can be referred to in the text as unpublished observations. If details of methods are only available in papers that are 'in press' , copies of the papers should be included with the manuscript submitted to 'Neuroimmunomodulation' , so that the editorial referees can have adequate information to judge the manuscript.
Examples (a) Papers published in periodicals:
Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists.
Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org.
Supplementary Material
Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modification or editing. In general, supplementary files should not exceed 10 MB in size. All figures and tables should have titles and legends and all files should be supplied separately and named clearly. Acceptable files and formats are: Word or PDF files, Excel spreadsheets (only if the data cannot be converted properly to a PDF file), and video files (.mov, .avi, .mpeg).
Author's Choice
TM
Karger's Author's Choice TM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3000.-, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
NIH-Funded Research
The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits the final version of your article on your behalf to PubMed Central. For those selecting our premium Author's Choice TM service, we will send your article immediately upon publishing, accelerating the accessibility of your work without the usual embargo. More details on NIH's Public Access Policy is available at http://publicaccess.nih.gov/policy.htm
Disclaimer:
The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor(s). The appearance of advertisements in the journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 
